Comparative Analysis of Icarrin and Curcumol as a Therapy for Pancreatic Cancer and Breast Cancer

Authors

  • Yuning Wang

DOI:

https://doi.org/10.61173/rc0bfb69

Keywords:

—Breast cancer, Pancreatic cancer, Phos-phatidylinositide 3-kinases signaling pathway, Traditional Chinese Medicine

Abstract

Breast cancer is the second most common type of cancer in American women. The incidence of pancreatic cancer has significantly risen over the past few decades. This study investigates whether icariin (ICA) and curcumin can show a more pronounced ability to inhibit tumor cell proliferation, induce apoptosis, and suppress cell migration and invasion in pancreatic and breast cancers. However, the specific impacts on different cancer types may vary. The objective of this research is to assess and compare the influence of ICA and curcumol on SNU-2466 pancreatic cancer cells and MCF7 breast cancer cells. The findings demonstrate that ICA and curcumol demonstrate a better effect on pancreatic cancer cells than in MCF7 breast cancer cells. Additionally, these compounds exhibit a stronger inhibitory effect on the PI3K/Akt/mTOR signaling pathway in pancreatic cancer cells compared to breast cancer cells. These results suggest that ICA and curcumol have more significant therapeutic potential in treating pancreatic cancer.

References

[1] https://www.iarc.who.int/faq/latest-global-cancer-data-2020- qa/.

[2] Global Cancer Incidence and Mortality Rates and Trends- -An Update Lindsey A Torre 1, Rebecca L Siegel 2, Elizabeth M Ward 3, Ahmedin Jemal 2 Affiliations expand PMID: 26667886DOI: 10.1158/1055-9965.EPI-15-0578.

[3] The effect of icariin on immunity and its potential application Rong Shen 1 2, Ju-Hua Wang 2 Affiliations expand PMID: 30038846 PMCID: PMC6055068.

[4] https://www.iarc.who.int/cancer-type/breast-cancer/

[5] Global Cancer Incidence and Mortality Rates and Trends-- An Update Lindsey A Torre 1, Rebecca L Siegel 2, Elizabeth M Ward 3, Ahmedin Jemal 2 Affiliations expand PMID: 26667886 DOI: 10.1158/1055-9965.EPI-15-0578.

[6] Pancreatic cancer Audrey Vincent 1, Joseph Herman, Rich Schulick, Ralph H Hruban, Michael Goggins Affiliations expand PMID: 21620466 PMCID: PMC3062508 DOI: 10.1016/S0140- 6736(10)62307-0.

[7] Park W, Chawla A, O’Reilly EM. Pancreatic Cancer: A Review. JAMA. 2021 Sep 7;326(9):851-862. doi: 10.1001/jama.2021.13027. Erratum in: JAMA. 2021 Nov 23;326(20):2081. doi: 10.1001/jama.2021.19984. PMID: 34547082; PMCID: PMC9363152.

[8] http://seer.cancer.gov/statfacts/html/pancreas.html.

[9] Pancreatic Cancer: Screening August 06, 2019

[10] Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, Accessed 05 October 2018.

[11] Traditional Chinese medicine and lung cancer--From theory to practice Zhang Li 1, Zhang Feiyue 1, Li Gaofeng 2 Affiliations expand PMID: 33601147DOI: 10.1016/j.biopha.2021.111381.

[12] Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer researchersnjing Xu1 | Jin Ding2 | Bonan Li3,4 Qinghu He3,5 | researchersn Sheng3,6DOI: 10.1002/ biof.1927.

[13] Knockout of LINC01134 as a potential treatment for Liver Cancer in HepG2cells. DOI: 10.1002/biof.1927.

[14] The effect of icariin on immunity and its potential application Rong Shen 1 2, Ju-Hua Wang 2 Affiliations expand PMID: 30038846 PMCID: PMC6055068

[15] Sai X, Li Z, Deng G, Wang L, Xiaowu W, Nasser MI, et al. Immunomodulatory effects of icariin in a myocardial infarction mouse model. Bioengineered. 2022;13:12504–15.

[16] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer Antonino Glaviano 1, Aaron S C Foo 2, Hiu Y Lam 3 4, Kenneth C H Yap 3 4, William Jacot 5, Robert H Jones 6 Affiliations expand PMID: 37596643 PMCID: PMC10436543 DOI: 10.1186/s12943-023-01827-6.

[17] Atorvastatin Inhibits Viability and Migration of MCF7 Breast Cancer Cells Asian Pac J Cancer Prev. 2022 Mar; 23(3): 867–875. DOI: 10.31557/APJCP.2022.23.3.867.

[18] Curcumin (Curcuma, Turmeric) and Cancer (PDQ®)– Patient Version.

[19] Applications of researchersstern blot technique: From bench to bedside Gholam Hossein Meftahi 1, Zahra Bahari 2, Ali Zarei Mahmoudabadi 3, Maryam Iman 4, Zohreh Jangravi 3 5 Affiliations expand PMID: 33847452 DOI: 10.1002/bmb.21516.

[20] https://wiki.antpedia.com/article-2332556

[21] https://baijiahao.baidu.com/s?id=1770392853850142047& wfr=spider&for=pc

[22] Applications of researchersstern blot technique: From bench to bedside Gholam Hossein Meftahi 1, Zahra Bahari 2, Ali Zarei Mahmoudabadi 3, Maryam Iman 4, Zohreh Jangravi 3 5 Affiliations expand PMID: 33847452 DOI: 10.1002/bmb.21516. Dean&Francis Yuning Wang

[23] DTL promotes cancer progression by PDCD4 ubiquitindependent degradation J Exp Clin Cancer Res. 2019; 38: 350. Published online 2019 Aug 13. doi: 10.1186/s13046-019-1358-x.

[24] Evaluation of the Cell Invasion and Migration Process: A Comparison of the Video Microscope-based Scratch Wound Assay and the Boyden Chamber Assay Published online 2017 Nov 17. doi: 10.3791/56337.

[25] https://www.creative-proteomics.com/blog/index.php/cellmigration-assay/

[26] Kao WT, Lin CY, Lee LT, Lee PP, Hung CC, Lin YS, Chen SH, Ke FC, Hwang JJ, Lee MT. Investigation of MMP- 2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Res. 2008 Jul- Aug;28(4B):2109-20. PMID: 18751383.

[27] Salim NN, Feig AL. Isothermal titration calorimetry of RNA. Methods. 2009 Mar;47(3):198-205. doi: 10.1016/ j.ymeth.2008.09.003. Epub 2008 Oct 7. PMID: 18835447; PMCID: PMC2673467.

[28] Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol. 1997 Dec;8(12):1197-206. doi: 10.1023/a:1008209720526. PMID: 9496384.

[29] Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. DOI: 10.1038/s41392-021-00762-

[30] Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012 Jun 8;149(6):1192-205. doi: 10.1016/ j.cell.2012.05.012. PMID: 22682243.

[31] Monaghan TF, Rahman SN, Agudelo CW, Wein AJ, Lazar JM, Everaert K, Dmochowski RR. Foundational Statistical Principles in Medical Research: Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value. Medicina (Kaunas). 2021 May 16;57(5):503. doi: 10.3390/ medicina57050503. PMID: 34065637; PMCID: PMC8156826.

[32] Ethylene Oxide: Cancer Evidence Integration and Dose- Response Implications DOI: 10.1177/1559325819888317

[33] Biologic concentration testing in inflammatory bowel disease. Inflamm Bowel Dis. 2015 Jun;21(6):1435-42. doi: 10.1097/MIB.0000000000000312. PMID: 25590953; PMCID: PMC4437804.

[34] Schellenberg LM, Regenthal R, Abraham G. The Rho kinase (ROCK) inhibitor Y-27632 reduces the β2- adrenoceptor density but enhance cAMP formation in primary equine bronchial epithelial cells. Eur J Pharmacol. 2021 Sep 15;907:174323. doi: 10.1016/j.ejphar.2021.174323. Epub 2021 Jul 8. Erratum in: Eur J Pharmacol. 2022 Jan 15;915:174724. doi: 10.1016/j.ejphar.2021.174724. PMID: 34246652.

[35] The matrix metalloproteinase inhibitor marimastat inhibits seizures in a model of kainic acid-induced status epilepticus DOI: 10.1038/s41598-020-78341-y

[36] Single-cell RNA sequencing technologies and applications: A brief overview DOI: 10.1002/ctm2.694

[37] Genome modification by CRISPR/Cas9 DOI: 10.1111/ febs.13110

Downloads

Published

2025-07-06